Double-Dose stem cell therapy shows promise for tough childhood cancer

NCT ID NCT02605421

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving two rounds of very strong chemotherapy, each followed by a stem cell transplant using the patient's own cells, can help children and young adults with high-risk neuroblastoma stay cancer-free longer. Participants must have already completed initial chemotherapy and have enough stored stem cells. The goal is to improve survival without the cancer coming back.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neuroblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Masonic Cancer Center, University of Minnesota

    RECRUITING

    Minneapolis, Minnesota, 55455, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••